1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidences of neuralgia due to the rise in the aging population
5.1.1.2. Government initiatives to spread awareness regarding neuralgia treatment products
5.1.2. Restraints
5.1.2.1. High-cost associated with the treatment of neuralgia
5.1.3. Opportunities
5.1.3.1. Technological advancement eliminates the need for drugs and surgery
5.1.3.2. Developing surgical and pharmacological treatment in developing economies
5.1.4. Challenges
5.1.4.1. Persistent side effects from medications
5.2. Cumulative Impact of COVID-19

6. Trigeminal Neuralgia Therapeutics Market, by Product Type
6.1. Introduction
6.2. Drug Based
6.2.1. Anticonvulsant Medicines
6.2.2. Tricyclic Antidepressants
6.3. Surgery
6.3.1. Microvascular Decompression
6.3.2. Radiofrequency Thermal Lesioning
6.3.3. Stereotactic Radiosurgery

7. Trigeminal Neuralgia Therapeutics Market, by End-user
7.1. Introduction
7.2. Ambulatory Surgery Centers
7.3. Hospital & Clinics

8. Americas Trigeminal Neuralgia Therapeutics Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Trigeminal Neuralgia Therapeutics Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand

10. Europe, Middle East & Africa Trigeminal Neuralgia Therapeutics Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. Alpha Therapeutics LLC
12.2. AMBOSS GmbH
12.3. Biogen Inc.
12.4. Cadila Healthcare Limited
12.5. CAPNIA, Inc.
12.6. Cephalon Inc.
12.7. Danaher Corporation
12.8. GlaxoSmithKline PLC
12.9. GLENMARK PHARMS LTD.
12.10. H. Lundbeck A/S
12.11. Johnson & Johnson Services, Inc.
12.12. Karger AG
12.13. LGM Pharma LLC
12.14. Lupin Limited
12.15. Novartis AG
12.16. Pfizer Inc.
12.17. Psychotropics India Limited
12.18. Takeda Pharmaceutical Company Limited
12.19. Teikoku Pharma USA, Inc.
12.20. Teva Pharmaceuticals Ltd.
12.21. Torrent Pharmaceuticals Ltd.
12.22. UCB Group
12.23. WINSTON PHARMACEUTICALS, Inc.

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing

List of Figures

FIGURE 1. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET: MARKET DYNAMICS
FIGURE 3. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2020 VS 2027 (%)
FIGURE 4. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2020 VS 2027 (USD MILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2027
FIGURE 6. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DRUG BASED, 2018-2027 (USD MILLION)
FIGURE 7. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DRUG BASED, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 8. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY ANTICONVULSANT MEDICINES, 2018-2027 (USD MILLION)
FIGURE 9. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY ANTICONVULSANT MEDICINES, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 10. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY TRICYCLIC ANTIDEPRESSANTS, 2018-2027 (USD MILLION)
FIGURE 11. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY TRICYCLIC ANTIDEPRESSANTS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 12. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2027 (USD MILLION)
FIGURE 13. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGERY, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 14. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY MICROVASCULAR DECOMPRESSION, 2018-2027 (USD MILLION)
FIGURE 15. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY MICROVASCULAR DECOMPRESSION, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 16. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY RADIOFREQUENCY THERMAL LESIONING, 2018-2027 (USD MILLION)
FIGURE 17. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY RADIOFREQUENCY THERMAL LESIONING, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 18. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY STEREOTACTIC RADIOSURGERY, 2018-2027 (USD MILLION)
FIGURE 19. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY STEREOTACTIC RADIOSURGERY, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 20. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END-USER, 2020 VS 2027 (%)
FIGURE 21. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END-USER, 2020 VS 2027 (USD MILLION)
FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END-USER, 2027
FIGURE 23. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2027 (USD MILLION)
FIGURE 24. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 25. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY HOSPITAL & CLINICS, 2018-2027 (USD MILLION)
FIGURE 26. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 27. AMERICAS TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 28. ARGENTINA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 29. BRAZIL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 30. CANADA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 31. MEXICO TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 32. UNITED STATES TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 33. ASIA-PACIFIC TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 34. AUSTRALIA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 35. CHINA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 36. INDIA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 37. INDONESIA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 38. JAPAN TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 39. MALAYSIA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 40. PHILIPPINES TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 41. SINGAPORE TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 42. SOUTH KOREA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 43. TAIWAN TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 44. THAILAND TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 45. EUROPE, MIDDLE EAST & AFRICA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 46. FRANCE TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 47. GERMANY TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 48. ITALY TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 49. NETHERLANDS TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 50. QATAR TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 51. RUSSIA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 52. SAUDI ARABIA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 53. SOUTH AFRICA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 54. SPAIN TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 55. UNITED ARAB EMIRATES TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 56. UNITED KINGDOM TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 57. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET: FPNV POSITIONING MATRIX
FIGURE 58. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 59. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET, BY TYPE

List of Tables

TABLE 1. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 4. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DRUG BASED, BY REGION, 2018-2027 (USD MILLION)
TABLE 5. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY ANTICONVULSANT MEDICINES, BY REGION, 2018-2027 (USD MILLION)
TABLE 6. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY TRICYCLIC ANTIDEPRESSANTS, BY REGION, 2018-2027 (USD MILLION)
TABLE 7. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGERY, BY REGION, 2018-2027 (USD MILLION)
TABLE 8. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY MICROVASCULAR DECOMPRESSION, BY REGION, 2018-2027 (USD MILLION)
TABLE 9. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY RADIOFREQUENCY THERMAL LESIONING, BY REGION, 2018-2027 (USD MILLION)
TABLE 10. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY STEREOTACTIC RADIOSURGERY, BY REGION, 2018-2027 (USD MILLION)
TABLE 11. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 12. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 13. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2027 (USD MILLION)
TABLE 14. AMERICAS TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 15. ARGENTINA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 16. BRAZIL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 17. CANADA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 18. MEXICO TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 19. UNITED STATES TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 20. ASIA-PACIFIC TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 21. AUSTRALIA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 22. CHINA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 23. INDIA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 24. INDONESIA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 25. JAPAN TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 26. MALAYSIA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 27. PHILIPPINES TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 28. SINGAPORE TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 29. SOUTH KOREA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 30. TAIWAN TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 31. THAILAND TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 32. EUROPE, MIDDLE EAST & AFRICA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 33. FRANCE TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 34. GERMANY TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 35. ITALY TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 36. NETHERLANDS TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 37. QATAR TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 38. RUSSIA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 39. SAUDI ARABIA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 40. SOUTH AFRICA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 41. SPAIN TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 42. UNITED ARAB EMIRATES TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 43. UNITED KINGDOM TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 44. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET: SCORES
TABLE 45. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET: BUSINESS STRATEGY
TABLE 46. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET: PRODUCT SATISFACTION
TABLE 47. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET: RANKING
TABLE 48. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 49. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET: MERGER & ACQUISITION
TABLE 50. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 51. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 52. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET: INVESTMENT & FUNDING
TABLE 53. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 54. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET: LICENSE & PRICING

Companies Mentioned

Alpha Therapeutics LLC
AMBOSS GmbH
Biogen Inc.
Cadila Healthcare Limited
CAPNIA, Inc.
Cephalon Inc.
Danaher Corporation
GlaxoSmithKline PLC
GLENMARK PHARMS LTD.
H. Lundbeck A/S
Johnson & Johnson Services, Inc.
Karger AG
LGM Pharma LLC
Lupin Limited
Novartis AG
Pfizer Inc.
Psychotropics India Limited
Takeda Pharmaceutical Company Limited
Teikoku Pharma USA, Inc.
Teva Pharmaceuticals Ltd.
Torrent Pharmaceuticals Ltd.
UCB Group
WINSTON PHARMACEUTICALS, Inc.